PROFUND ADVISORS LLC

Position in GERN — Geron Corp

CIK 1129919 BETHESDA, MD

Position in GERN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$392,430

-$195,984 QoQ

Shares Held

306,586

-22.4% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#79

of 258 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. GERN ranks #111 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$392,430	306,586	-22.4%	Shares	Sole	2026-08-11
2026-03-31	$588,414	394,909	+28.7%	Shares	Sole	2026-04-27
2025-12-31	$405,125	306,913	+43.8%	Shares	Sole	2026-02-06
2025-09-30	$292,448	213,466	+21.3%	Shares	Sole	2025-11-06
2025-06-30	$248,062	175,931	-5.2%	Shares	Sole	2025-08-07
2025-03-31	$294,933	185,493	-20.8%	Shares	Sole	2025-05-08
2024-12-31	$829,103	234,210	-16.8%	Shares	Sole	2025-02-14
2024-09-30	$1,278,096	281,519	+53.6%	Shares	Sole	2024-11-14
2024-06-30	$777,005	183,256	-51.3%	Shares	Sole	2024-08-13
2024-03-31	$1,241,988	376,360	+36.4%	Shares	Sole	2024-05-08
2023-12-31	$581,986	275,823	-14.6%	Shares	Sole	2024-02-14
2023-09-30	$684,456	322,857	+31.7%	Shares	Sole	2023-11-13
2023-06-30	$786,970	245,162	-28.6%	Shares	Sole	2023-08-10
2023-03-31	$745,616	343,602	+3232.4%	Shares	Sole	2023-05-12
2021-12-31	$12,579	10,311	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.